PMID- 31173178 OWN - NLM STAT- MEDLINE DCOM- 20191223 LR - 20211204 IS - 1791-244X (Electronic) IS - 1107-3756 (Print) IS - 1107-3756 (Linking) VI - 44 IP - 2 DP - 2019 Aug TI - Strontium promotes osteogenic differentiation by activating autophagy via the the AMPK/mTOR signaling pathway in MC3T3‑E1 cells. PG - 652-660 LID - 10.3892/ijmm.2019.4216 [doi] AB - Strontium (Sr) is an alkaline earth metal that exerts the dual effect of improving bone formation and suppressing bone resorption, resulting in increased bone apposition rates and bone mineral density. However, the mechanisms through which Sr exerts these beneficial effects on bone have yet to be fully elucidated. The present study aimed to reveal the underlying molecular mechanisms associated with Sr‑induced osteogenic differentiation. The effects of Sr on cell proliferation and osteogenic differentiation were analyzed by MTT assay, RT‑qPCR, western blot analysis, alkaline phosphatase (ALP) and Alizarin red staining assays. The extent of autophagy was determined by monodansylcadaverine (MDC) staining and western blot analysis of two markers of cellular autophagic activity, the steatosis‑associated protein, sequestosome‑1 (SQSTM1/p62), and the two isoforms of microtubule‑associated protein 1 light chain 3 (LC3), LC‑3‑I/II. The expression levels of AMP‑activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) were also detected by western blot analysis. Sr at a concentration of 3 mM exerted the most pronounced effect on osteogenic differentiation, without any apparent cell toxicity. At the same time, cellular autophagy was active during this process. Subsequently, autophagy was blocked by 3‑methyladenine, and the enhancement of osteogenic differentiation in response to Sr was abrogated. Additionally, the phosphorylation level of AMPK was significantly increased, whereas that of mTOR was significantly decreased, in the Sr‑treated group. Taken together, the findings of the present study demonstrate that Sr stimulates AMPK‑activated autophagy to induce the osteogenic differentiation of MC3T3‑E1 cells. FAU - Cheng, You AU - Cheng Y AD - School of Medical Laboratory, Tianjin Medical University, Tianjin 300070, P.R. China. FAU - Huang, Lunhui AU - Huang L AD - School of Medical Laboratory, Tianjin Medical University, Tianjin 300070, P.R. China. FAU - Wang, Yichao AU - Wang Y AD - Department of Clinical Laboratory Medicine, Taizhou University Hospital, Taizhou, Zhejiang 318000, P.R. China. FAU - Huo, Qianyu AU - Huo Q AD - School of Medical Laboratory, Tianjin Medical University, Tianjin 300070, P.R. China. FAU - Shao, Yanhong AU - Shao Y AD - School of Medical Laboratory, Tianjin Medical University, Tianjin 300070, P.R. China. FAU - Bao, Huijing AU - Bao H AD - School of Medical Laboratory, Tianjin Medical University, Tianjin 300070, P.R. China. FAU - Li, Zhaoyang AU - Li Z AD - School of Materials Science and Engineering, Tianjin University, Tianjin 300350, P.R. China. FAU - Liu, Yunde AU - Liu Y AD - School of Medical Laboratory, Tianjin Medical University, Tianjin 300070, P.R. China. FAU - Li, Xue AU - Li X AD - School of Medical Laboratory, Tianjin Medical University, Tianjin 300070, P.R. China. LA - eng PT - Journal Article DEP - 20190530 PL - Greece TA - Int J Mol Med JT - International journal of molecular medicine JID - 9810955 RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - EC 2.7.11.31 (AMP-Activated Protein Kinases) RN - YZS2RPE8LE (Strontium) SB - IM MH - AMP-Activated Protein Kinases/*metabolism MH - Animals MH - Autophagy/*drug effects MH - Cell Differentiation/drug effects MH - Cell Line MH - Mice MH - Osteogenesis/*drug effects MH - Signal Transduction/drug effects MH - Strontium/*pharmacology MH - TOR Serine-Threonine Kinases/*metabolism PMC - PMC6605659 EDAT- 2019/06/08 06:00 MHDA- 2019/12/24 06:00 PMCR- 2019/05/30 CRDT- 2019/06/08 06:00 PHST- 2019/01/09 00:00 [received] PHST- 2019/05/24 00:00 [accepted] PHST- 2019/06/08 06:00 [pubmed] PHST- 2019/12/24 06:00 [medline] PHST- 2019/06/08 06:00 [entrez] PHST- 2019/05/30 00:00 [pmc-release] AID - ijmm-44-02-0652 [pii] AID - 10.3892/ijmm.2019.4216 [doi] PST - ppublish SO - Int J Mol Med. 2019 Aug;44(2):652-660. doi: 10.3892/ijmm.2019.4216. Epub 2019 May 30.